SecBot SecBot
8-K ·Filed Sep 22, 2026

PETV

PetVivo Holdings, Inc.
NEUTRAL
Impact 2/10
Horizonmonths Processed1mo ago SEC0001493152-26-043641
8-K context-dependent: Items 5.02
Actionable Insight • Neutral

Monitor for any future strategic transactions or capital raises that Handley's experience may facilitate, but this filing is a routine governance matter with no immediate trading implications.

DirectionNeutral
Confidencehigh
Horizonmonths
Latest settled — T+20d ⚠ clustered
PETV ▼ -10.12% at T+20d
NEUTRAL call -10.12% · α vs SPY -9.56% · entry $0.8400 → $0.7550
Next anchor: T+60d in 7w
Latest observation: T+23 -16.22% FF3 residual α
Entry = T+0 close
Sep 22, 2026
via day close
T+1d
0.00%
call 0.00% · α +0.72%
$0.8400
settled 5w ago
T+5d
-5.12%
call -5.12% · α -3.93%
$0.7970
settled 28d ago
T+20d
-10.12%
call -10.12% · α -9.56%
$0.7550
settled 7d ago
T+60d
Pending
in 7w

Price Chart

Loading chart...

Executive Summary

PetVivo Holdings announced the resignation of director Joseph Jasper and the appointment of Michael K. Handley to its board, effective September 22, 2026. Handley is a seasoned life sciences executive with over 25 years of experience, having raised over $700 million in capital and contributed to transactions exceeding $4 billion. This is a routine board refresh with no disagreement cited for Jasper's departure, and the board size remains at six directors.

Key Facts

  • Joseph Jasper resigned from the board effective September 22, 2026, with no disagreement with the company.
  • Michael K. Handley was appointed as a director effective September 22, 2026, filling the vacancy.
  • Handley has over 25 years of life sciences experience, raised over $700 million in capital, and contributed to transactions exceeding $4 billion.
  • Board size remains at six directors.
  • Handley will serve as a non-employee director with compensation consistent with other non-employee directors.

Financial Impact

No financial impact from this board change.

Risk Factors

  • No material risks identified from this board change.

Investment Themes

Healthcare & Medical Devices

Documents Analyzed

This report is based on 5 SEC documents filed with EDGAR.

DocumentAccession Number
8-K Filing (Primary)0001493152-26-043641
Exhibit: ex99-1.htm0001493152-26-043641
Document: 0001493152-26-043641-index-headers.html0001493152-26-043641
Document: 0001493152-26-043641-index.html0001493152-26-043641
Document: 0001493152-26-043641.txt0001493152-26-043641
5 reports for PETV
Performance horizon

Track record builds as more directional reports settle.

Filters
Rows
Reports for PETV — sortable, filterable
TypeNow
Sep 22, 2026
5w ago
8-K
NEUTRAL ★ 2/10
$0.8400awaiting T+60—$0.6690 (−20.36%)
Sep 22, 2026
5w ago
8-K
NEUTRAL ★ 2/10
$0.8400awaiting T+60—$0.6690 (−20.36%)
Aug 20, 2026
9w ago
8-K
NEUTRAL ★ 2/10
$0.7000awaiting T+60—$0.6690 (−4.43%)
Jul 27, 2026
13w ago
8-K
BEARISH ★ 7/10
$0.6240 $0.7500▼ −20.19%▼ −15.72%$0.6690 (−7.21%)
Mar 4, 2026
33w ago
8-K
NEUTRAL ★ 3/10
$0.7800 $0.7980▲ +2.31%▼ −7.78%$0.6690 (−14.23%)
Showing 5 of 5

US Market Status

Market Closed — Opens Wed (< 1m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Sep 22, 2026